Press Releases Year All Years 2020 2019 2018 2017 2016 2015 2014 Category All Releases Financial Releases Recro Pharma Reports Second Quarter 2019 Financial Results Aug 08, 2019 7:14am EDT Recro Pharma to Report Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019 Aug 01, 2019 7:00am EDT Recro Pharma to Present at Upcoming Investor Conferences May 30, 2019 7:00am EDT Recro Pharma Reports First Quarter 2019 Financial Results May 10, 2019 7:00am EDT Recro Pharma to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 10, 2019 May 06, 2019 7:00am EDT Recro Pharma Announces Six-Year Extension of License and Supply Agreement Between Teva and Recro Gainesville Apr 16, 2019 7:00am EDT Recro Pharma Announces Presentation of New Meta-Analysis for IV Meloxicam at the 44th Annual Regional Anesthesiology and Acute Pain Medicine Meeting Apr 11, 2019 4:05pm EDT Recro Pharma Restructures Acute Care Segment While Continuing To Execute on Strong CDMO Segment Performance Apr 03, 2019 4:05pm EDT Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors Mar 25, 2019 7:00am EDT Recro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam Mar 22, 2019 3:30pm EDT Prev 1 2 3 4 5 6 7 8 9 10 ...17 Next
Recro Pharma to Report Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019 Aug 01, 2019 7:00am EDT
Recro Pharma to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 10, 2019 May 06, 2019 7:00am EDT
Recro Pharma Announces Six-Year Extension of License and Supply Agreement Between Teva and Recro Gainesville Apr 16, 2019 7:00am EDT
Recro Pharma Announces Presentation of New Meta-Analysis for IV Meloxicam at the 44th Annual Regional Anesthesiology and Acute Pain Medicine Meeting Apr 11, 2019 4:05pm EDT
Recro Pharma Restructures Acute Care Segment While Continuing To Execute on Strong CDMO Segment Performance Apr 03, 2019 4:05pm EDT
Recro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam Mar 22, 2019 3:30pm EDT